Brief: Grand Pharmaceutical Group Says Investigational New Drug Application Of GPN00884 Was Accepted By China's NMPA
27/12/2023 09:52
Dec 27 (Reuters) - Grand Pharmaceutical Group Ltd
0512.HK :
* INVESTIGATIONAL NEW DRUG APPLICATION OF GPN00884 WAS
ACCEPTED BY
CHINA'S NMPA
Source text for Eikon: ID:
Further company coverage: 0512.HK
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Grand Pharmaceutical
See all newsBrief: Grand Pharmaceutical Group Declares No Interim Dividend Has Been Paid
Grand Pharmaceutical H1 revenue rises on nuclear medicine demand
Grand Pharma rises most in over a year as drug gets US FDA fast track designation
GPN01530-2 Granted Fast Track Designation By FDA
Brief: Grand Pharmaceutical Group Enters Huadong Medicine Supply Agreement